Basel Medical Group Statistics
Total Valuation
BMGL has a market cap or net worth of $10.65 million. The enterprise value is $17.39 million.
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BMGL has 1.57 million shares outstanding. The number of shares has decreased by -67.81% in one year.
| Current Share Class | 1.57M |
| Shares Outstanding | 1.57M |
| Shares Change (YoY) | -67.81% |
| Shares Change (QoQ) | +31.21% |
| Owned by Insiders (%) | 13.65% |
| Owned by Institutions (%) | 0.32% |
| Float | 501,419 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.78 |
| Forward PS | n/a |
| PB Ratio | 26.44 |
| P/TBV Ratio | 2.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.26 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.88, with a Debt / Equity ratio of 1.51.
| Current Ratio | 1.88 |
| Quick Ratio | 1.84 |
| Debt / Equity | 1.51 |
| Debt / EBITDA | 6.51 |
| Debt / FCF | n/a |
| Interest Coverage | -4.25 |
Financial Efficiency
Return on equity (ROE) is -147.37% and return on invested capital (ROIC) is -9.10%.
| Return on Equity (ROE) | -147.37% |
| Return on Assets (ROA) | -4.88% |
| Return on Invested Capital (ROIC) | -9.10% |
| Return on Capital Employed (ROCE) | -10.87% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $167,841 |
| Profits Per Employee | -$95,281 |
| Employee Count | 82 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 58.65 |
Taxes
| Income Tax | -188,067 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -67.62% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -67.62% |
| 50-Day Moving Average | 7.41 |
| 200-Day Moving Average | 10.95 |
| Relative Strength Index (RSI) | 44.63 |
| Average Volume (20 Days) | 151,454 |
Short Selling Information
The latest short interest is 314,368, so 20.08% of the outstanding shares have been sold short.
| Short Interest | 314,368 |
| Short Previous Month | 16,824 |
| Short % of Shares Out | 20.08% |
| Short % of Float | 62.70% |
| Short Ratio (days to cover) | 0.19 |
Income Statement
In the last 12 months, BMGL had revenue of $13.76 million and -$7.81 million in losses. Loss per share was -$2.78.
| Revenue | 13.76M |
| Gross Profit | 3.91M |
| Operating Income | -1.06M |
| Pretax Income | -8.09M |
| Net Income | -7.81M |
| EBITDA | -848,211 |
| EBIT | -1.06M |
| Loss Per Share | -$2.78 |
Full Income StatementBalance Sheet
The company has $1.04 million in cash and $7.67 million in debt, giving a net cash position of -$6.63 million or -$4.24 per share.
| Cash & Cash Equivalents | 1.04M |
| Total Debt | 7.67M |
| Net Cash | -6.63M |
| Net Cash Per Share | -$4.24 |
| Equity (Book Value) | 5.07M |
| Book Value Per Share | 0.26 |
| Working Capital | 5.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.47 million and capital expenditures -$8.55 million, giving a free cash flow of -$9.97 million.
| Operating Cash Flow | -1.47M |
| Capital Expenditures | -8.55M |
| Depreciation & Amortization | 215,544 |
| Net Borrowing | -4.40M |
| Free Cash Flow | -9.97M |
| FCF Per Share | -$6.37 |
Full Cash Flow StatementMargins
Gross margin is 28.42%, with operating and profit margins of -7.74% and -56.77%.
| Gross Margin | 28.42% |
| Operating Margin | -7.74% |
| Pretax Margin | -58.75% |
| Profit Margin | -56.77% |
| EBITDA Margin | -6.16% |
| EBIT Margin | -7.74% |
| FCF Margin | n/a |